Structures by: Neelakantan M. A.
Total: 8
(E)-4-((2-hydroxyethylimino) methyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol
C10H14N2O3
Anal. Methods (2014) 6, 24 9610
a=16.3383(13)Å b=9.6603(13)Å c=13.6431(12)Å
α=90.00° β=113.262(7)° γ=90.00°
C26H24N2NiO4
C26H24N2NiO4
RSC Adv. (2016)
a=7.8251(5)Å b=19.6656(13)Å c=14.6693(11)Å
α=90.00° β=100.416(3)° γ=90.00°
C26H24CuN2O4
C26H24CuN2O4
RSC Adv. (2016)
a=10.4808(12)Å b=9.5955(8)Å c=22.932(2)Å
α=90.00° β=93.828(5)° γ=90.00°
2-Hydroxy-4-(prop-2-ynyloxy)benzaldehyde
C10H8O3
Acta Crystallographica Section E (2013) 69, 1 o64
a=7.0835(5)Å b=10.4059(7)Å c=12.8461(8)Å
α=73.910(3)° β=89.756(4)° γ=73.436(4)°
2,4-Bis[(prop-2-ynyl)oxy]benzaldehyde
C13H10O3
Acta Crystallographica Section E (2012) 68, 8 o2465
a=4.9219(2)Å b=16.8705(7)Å c=13.4326(6)Å
α=90.00° β=98.236(3)° γ=90.00°
1-[2-Hydroxy-4-(prop-2-yn-1-yloxy)phenyl]ethan-one
C11H10O3
Acta Crystallographica Section E (2014) 70, 1 o24
a=4.9975(2)Å b=10.4305(4)Å c=18.8467(7)Å
α=90.00° β=97.257(2)° γ=90.00°
N-o-vanillylidene-L-histidine; 3-methoxysalicylidene-L-histidine; N-(2-oxy-3-methoxy-benzylidene)-L-histidine
C14H15N3O4,H2O
Crystal Growth & Design (2010) 10, 4 1665
a=8.6155(3)Å b=11.6223(4)Å c=14.8504(6)Å
α=90.00° β=90.00° γ=90.00°
N-o-vanillylidene-L-histidine; 3-methoxysalicylidene-L-histidine; N-(2-oxy-3-methoxy-benzylidene)-L-histidine
C14H15N3O4,H2O
Crystal Growth & Design (2010) 10, 4 1665
a=8.6115(1)Å b=11.6104(1)Å c=14.7472(1)Å
α=90° β=90° γ=90°